Product information

From Health Canada

Current status:

Marketed

Current status date:

2013-04-20

Original market date: See footnote 1

1950-12-31

Product name:

NEO-LARYNGOBIS

DIN:

00065927 Electronic product monograph is not available

Company:

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Suppository

Route(s) of administration:

Rectal

Number of active ingredient(s):

1

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

52:92.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

R02AA20 VARIOUS

Active ingredient group (AIG) number:See footnote5

0108681002

List of active ingredient(s)
Active ingredient(s) Strength
BISMUTH DIPROPYLACETATE 135 MG
Version 4.0.2
Date modified: